Osteocalcin may recruit osteoclast precursors and promote the differentiation of osteoclast precursors into osteoclasts, suggesting that osteocalcin may be a new target for the treatment of osteopenia or osteoporosis (Lambert et al., 2016). This evidence concerns the gene BGLAP and osteoporosis.